Outlook Therapeutics, Inc. ($OTLK)
Haddadin Yezan Munther โ Director
Shares
34,000
Price
$0.44
Total Value
$14,960.00
P&L
+84.0% (+$12,573.20)
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Haddadin Yezan Munther |
|---|---|
| Title | Director |
| Transaction Date | May 26, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | May 27, 2026 |
| Shares Purchased | 34,000 |
| Price per Share | $0.44 |
| Total Value | $14,960.00 |
| Shares Owned After | 37,167 |
| Derivative | No |
| Accession Number | 0001649989-26-000003 |
| Document | View SEC Filing |